Quantcast

Latest Cordis Stories

2013-09-19 23:21:39

Reportbuyer.com just published a new market research report: MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts. London (PRWEB) September 19, 2013 Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon...

2013-05-10 23:04:57

According to a new market report published by Transparency Market Research "Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global peripheral vascular devices market was valued at USD 4.8 billion in 2011 and is estimated to reach a...

2012-09-12 23:03:39

Research reveals an aging population and increasing obesity rates fuel the 1.1 Billion dollar Endovascular devices market in Europe. (PRWEB) September 11, 2012 Most peripheral vascular devices in Europe are used for the treatment of peripheral arterial disease (PAD). PAD is characterized by the hardening and thickening of arteries resulting from the accumulation of fatty tissue and cholesterol. The prevalence of PAD increases with age and the existence of predisposing conditions such as...

2012-02-15 12:45:00

Survey Reveals Most Cardiologists Would Use a Bioabsorbable Stent for Coronary Angioplasty According to iData Research Vancouver, BC (PRWEB) February 15, 2012 According to a new market monitoring service from iData Research (http://www.idataresearch.net), the leading global authority in medical device market research, Cordis, Boston Scientific and Abbott Vascular were the preferred stent brands in the U.S., Europe, Middle East and Africa, while Medtronic had a strong market presence in...

2011-06-15 08:01:00

NEW BRUNSWICK, N.J., June 15, 2011 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that it expects to record an after-tax restructuring charge in the range of $500-$600 million in the second quarter of 2011 as a result of restructuring plans announced by its subsidiary, Cordis Corporation. The restructuring charge will be treated as a special item. In its separate news release today, Cordis announced the discontinuation of its clinical development program for...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'